Literature DB >> 16432091

The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease.

Steven A Grover1, Ilka Lowensteyn, Mohammed Kaouache, Sylvie Marchand, Louis Coupal, Emidio DeCarolis, Joseph Zoccoli, Isabelle Defoy.   

Abstract

BACKGROUND: The prevalence of erectile dysfunction (ED) and associated risk factors has been described in many clinical settings, but there is little information regarding men seen by primary care physicians. We sought to identify independent factors associated with ED in a primary care setting.
METHODS: We surveyed a cross-sectional sample of 3921 Canadian men, aged 40 to 88 years, seen by primary care physicians. Participants completed a full medical history, physical examination, and measurement of fasting blood glucose and lipid levels. We used the International Index of Erectile Function to define ED as a score of less than 26 on the erectile function domain.
RESULTS: The overall prevalence of ED was 49.4%. The presence of cardiovascular disease (odds ratio [OR], 1.45; 95% confidence interval [CI], 1.16-1.81; P<.01) or diabetes (OR, 3.13; 95% CI, 2.35-4.16; P<.001) increased the probability of ED after adjustment for other confounders. Among those individuals without cardiovascular disease or diabetes, the calculated 10-year Framingham coronary risk (OR, 1.03 per 1% increase; 95% CI, 1.02-1.05; P<.001) and fasting blood glucose levels (OR, 1.14 per 18-mg/dL [1-mmol/L] increase; 95% CI, 1.04-1.24; P<.01) were independently associated with ED. Erectile dysfunction was also independently associated with undiagnosed hyperglycemia (OR, 1.46; 95% CI, 1.02-2.10; P = .04), impaired fasting glucose (OR, 1.26; 95% CI, 1.08-1.46; P = .004), and the metabolic syndrome (OR, 1.45; 95% CI, 1.24-1.69; P<.001).
CONCLUSIONS: Cardiovascular disease, diabetes, future coronary risk, and increasing fasting glucose levels are independently associated with ED. It remains to be determined if ED precedes the development of these conditions.

Entities:  

Mesh:

Year:  2006        PMID: 16432091     DOI: 10.1001/archinte.166.2.213

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  46 in total

1.  Erectile dysfunction in opioid users: lack of association with serum testosterone.

Authors:  Patricia A Cioe; Peter D Friedmann; Michael D Stein
Journal:  J Addict Dis       Date:  2010-10

2.  Routine cardiac assessment is not necessary for all patients with erectile dysfunction.

Authors:  Naif Alhathal; Serge Carrier
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

3.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

Review 4.  Emerging role for TNF-α in erectile dysfunction.

Authors:  Fernando S Carneiro; Robert Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2010-12       Impact factor: 3.802

5.  2015 CUA Practice guidelines for erectile dysfunction.

Authors:  Anthony J Bella; Jay C Lee; Serge Carrier; Francois Bénard; Gerald B Brock
Journal:  Can Urol Assoc J       Date:  2015 Jan-Feb       Impact factor: 1.862

6.  Diabetes severity, metabolic syndrome, and the risk of erectile dysfunction.

Authors:  Aviva E Weinberg; Michael Eisenberg; Chirag J Patel; Glenn M Chertow; John T Leppert
Journal:  J Sex Med       Date:  2013-09-09       Impact factor: 3.802

Review 7.  Prediabetes diagnosis and treatment: A review.

Authors:  Nidhi Bansal
Journal:  World J Diabetes       Date:  2015-03-15

8.  Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men.

Authors:  B M Hoffman; A Sherwood; P J Smith; M A Babyak; P M Doraiswamy; A Hinderliter; J A Blumenthal
Journal:  Int J Impot Res       Date:  2009-09-24       Impact factor: 2.896

9.  Association between erectile dysfunction and cardiovascular risk in individuals with type-2 diabetes without overt cardiovascular disease.

Authors:  Babu Lal Meena; Dhanpat Kumar Kochar; Tulsi Das Agarwal; Raghvendra Choudhary; Abhishek Kochar
Journal:  Int J Diabetes Dev Ctries       Date:  2009-10

10.  Preventing cardiovascular disease among Canadians: what are the potential benefits of treating hypertension or dyslipidemia?

Authors:  Steven A Grover; Louis Coupal; Mohammed Kaouache; Ilka Lowensteyn
Journal:  Can J Cardiol       Date:  2007-05-01       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.